- Zhang, et al. SARs of a novel series of s-triazine compounds targeting vimentin to induce methuotic phenotype. Eur J Med Chem. 2021 Mar 15;214:113188. doi: 10.1016/j.ejmech.2021.113188.
- Wu, et al: A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility. Frontiers in Pharmacol. 12:1597, 2021. doi: 10.3389/fphar.2021.627394.
- Li, et al. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. mBio. 2021 Oct 12:e0254221. doi: 10.1128/mBio.02542-21. Epub ahead of print. PMID: 34634931.
This document was printed from http://www.aludapharm.com/science/publications.html